Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of carbon dot as anti-tumor medicine carrier

An anti-tumor drug, carbon dot technology, applied in the field of nanomedicine, can solve the problems of protein non-specific adsorption, poor drug loading stability, increased drug side effects, etc., and achieves high drug loading rate, good water solubility, and high quantum yield. Effect

Active Publication Date: 2015-04-01
SOUTHEAST UNIV
View PDF2 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the method of loading doxorubicin on carbon dots based on physical adsorption (Lee H.U., Park S.Y. and Park E.S. et al., Sci. Rep. 2014, 4, 4665.) has the disadvantage of poor drug loading stability, which may It will cause the drug molecules to be released before reaching the target, which will increase the side effects of the drug and reduce the curative effect
And the strategy (Mewada A., Pandey S. and Thakur M. et al., J. Mater. Chem. B, 2014, 2, 698.) of directly linking doxorubicin molecules to carbon dots in a covalent bond mode, due to The poor solubility of doxorubicin itself will cause the instability of the final product and non-specific adsorption of proteins

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of carbon dot as anti-tumor medicine carrier
  • Application of carbon dot as anti-tumor medicine carrier
  • Application of carbon dot as anti-tumor medicine carrier

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] The preparation of thiolated doxorubicin comprises the following steps:

[0038] (1) Dissolve doxorubicin in a solution (pH=8.0) of dimethyl sulfoxide (DMSO) and phosphate buffer (PBS), and add Traut in the amount of 3 times the substance of doxorubicin ’ s reagent;

[0039] (2) React at room temperature for 1 hour to obtain thiolated doxorubicin.

Embodiment 2

[0041] Preparation of AEEA carbon dots, see figure 1 , including the following steps:

[0042] (1) Into the glycerol, feed nitrogen for 5 minutes to remove the oxygen in the glycerol;

[0043] (2) Add 3-[2-(2-aminoethylamino)ethylamino]propyltrimethoxysilane (AEEA) to glycerol to make its volume fraction 9.1% (5-30%), in a closed state Stir for more than 5 minutes to form a carbon dot precursor solution;

[0044] (3) React in a microwave reactor at 160°C for 15 minutes;

[0045] (4) Centrifuge to remove the precipitate generated, and leave the supernatant;

[0046] (5) Use a dialysis bag with a molecular weight of 1000 to dialyze the supernatant in ultrapure water for more than 48 hours (change the water every 6 hours) to obtain a pure carbon dot solution.

Embodiment 3

[0048] The preparation of aminated carbon dots is similar to that of Example 2, except that in step (3) the microwave reactor was reacted at 180°C for 5 minutes, and the 3-[2-(2-aminoethylamino)ethylamino]propane The volume fraction of trimethoxysilane (AEEA) is 5%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an application of a carbon dot as an anti-tumor medicine carrier. The application comprises the following steps: preparing an aminated carbon dot: by taking a silane reagent containing amino groups and glycerin as raw materials, preparing the aminated carbon dot by adopting a microwave synthesis process; performing maleimide treatment on the surface of the carbon dot: reacting the aminated carbon dot with a short-chain polyethylene glycol molecule NHS-EGn-MAL of which one end has N-hydroxysuccinimide ester and the other end has maleimide to obtain the carbon dot subjected to maleimide treatment; and preparing a carbon dot-medicine molecule complex: reacting the carbon dot subjected to maleimide treatment with a medicine with sulfhydryl groups to obtain the carbon dot-medicine molecule complex. The aminated carbon dot prepared by using a method provided by the invention is high in fluorescence quantum yield, good in water solubility and low in cytotoxicity, has a great number of modifiable genes on the surface, cannot cause coagulation after modifying a short-chain polyethylene glycol chain segment, and is a very ideal medicine carrier.

Description

technical field [0001] The invention relates to the application of carbon dots as antitumor drug carriers, belonging to the technical field of nanomedicine. Background technique [0002] Carbon is one of the most basic elements that make up organic organisms and is indispensable to all currently known living systems, without which life would not be possible. In recent years, various carbon materials (such as carbon nanotubes, graphene, fullerene, etc.) have been widely used in biological detection, catalysis, energy, electronic devices, and drug loading. Fluorescent carbon nanoparticles, as a new type of zero-dimensional carbon material, have attracted much attention due to their cheap raw materials, good biocompatibility, good photostability and easy surface modification. [0003] Due to the good biocompatibility and easy modification of carbon-based materials, they have been widely used in drug loading in recent years. Early related reports have mentioned graphene oxide a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K47/48A61K31/704A61P35/00
Inventor 吴富根杨婧婧张晓东王志飞陈战
Owner SOUTHEAST UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com